Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA synthesis inhibitors are a broad class of molecules that interfere with the replication and repair of DNA, thereby preventing cell division and proliferation. These agents are used as antimicrobials (antibacterials, antivirals), anticancer drugs, and in some cases for other hyperproliferative diseases. They act through several mechanisms, including topoisomerase inhibition, direct polymerase inhibition, nucleotide pool depletion, and DNA damage/modification.
Inhibition of DNA synthesis through various mechanisms, including topoisomerase inhibition, direct polymerase inhibition, nucleotide pool depletion, and DNA damage/modification.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Synthesis Inhibitor.